H.R. 2375 · 116th Congress

Preserve Access to Affordable Generics and Biosimilars Act

Stage
Reported from committee
Sponsor
Jerrold Nadler
Introduced
2019-04-29
Latest action
2020-12-24 · Reported by the Committee on Judiciary. H. Rept. 116-693, Part I.

Subjects

Administrative law and regulatory procedures
Congressional oversight
Health
Civil actions and liability
Licensing and registrations
Intellectual property
Prescription drugs
Marketing and advertising
Competition and antitrust
Judicial review and appeals
Contracts and agency
Federal Trade Commission (FTC)